If RVNC needs to raise 150M at 5 dollars that hurts no doubt. However they do have cash through some trial readouts which would presumably help the share price if positive. Based on that data they could either raise at a higher price or leverage that data to a deal on favorable terms with a partner. Between now and launch they would also have 2 milestones from Fosun and probably some additional money for the biosimilar as well
Market Data 
Markets 
AI
